Table 3.
Complications and adverse events
| Complications, n (%) | PVI (n = 59) | CTI ablation (n = 54) | P-value |
|---|---|---|---|
| Composite safety endpoint | 5 (8.5) | 6 (11.1) | 0.755 |
| Groin haematoma | 2 (3.4) | 0.497 | |
| All-cause hospitalisation* | 18 (30.5) | 12 (22.2) | 0.395 |
| Pericarditis | |||
| Pericardial effusion | 1 (1.7) | > 0.999 | |
| Phrenic nerve palsy | |||
| Requirement for pacemaker | 1 (1.7) | 5 (9.3) | 0.102 |
| Stroke or TIA | |||
| Myocardial infarction | 1 (1.7) | > 0.999 | |
| Atrio-oesophageal fistula | |||
| All-cause death | 3 (5.1) | 1 (1.9) | 0.620 |
CTI cavotricuspid isthmus ablation, PVI pulmonary vein isolation, TIA transient ischaemic attack
*All-cause hospitalisation is described here as a binary outcome, i.e., a patient either had a hospitalisation during follow-up or did not. Further details about all-cause hospitalisation is given in the text